MedPath

Melaleuca ProvexCV Capsule

Registration Number: MAL18116113N

Approved
Approval ID

a510ee6fe92ecc3a

Registration Number

MAL18116113N

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (6)

QUERCETIN DIHYDRATEActive
VITIS VINIFERA (GRAPE SEED EXTRACT)Active
Monograph: vitis vinifera (grape seed extract)
VACCINIUM MYRTILLUS FRUIT EXTRACT (BILBERRY)Active
Monograph: vaccinium myrtillus fruit extract (bilberry)
GINKGO BILOBA LEAF EXTRACTActive
Monograph: ginkgo biloba leaf extract
POLYGONUM CUSPIDATUM EXTRACTActive
Monograph: polygonum cuspidatum extract
Camellia Sinensis (Green Tea) Leaf ExtractActive
Monograph: camellia sinensis (green tea) leaf extract

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Melaleuca ProvexCV Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform